Fluorouracil 2.5gm/50ml Inj, 1 Vial

Manufacturer NOVAPLUS/APP PHARMACEUTICALS Active Ingredient Fluorouracil (Systemic)(flure oh YOOR a sil) Pronunciation flure oh YOOR a sil
It is used to treat cancer.
🏷️
Drug Class
Antineoplastic agent
🧬
Pharmacologic Class
Antimetabolite, Pyrimidine analog
🤰
Pregnancy Category
Category D
FDA Approved
Aug 1962
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fluorouracil is a chemotherapy drug used to treat various types of cancer. It works by interfering with the growth of cancer cells, which are fast-growing cells in the body. It can be given by injection into a vein.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. Take this medication exactly as directed, and be sure to follow all instructions provided. This medication is administered via injection into a vein, either as a single dose or continuously over a period of time.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage procedures.

If you miss a dose, contact your doctor immediately to determine the best course of action.
💡

Lifestyle & Tips

  • Avoid contact with people who are sick or have infections, as your immune system will be weakened.
  • Practice good hand hygiene.
  • Avoid crowded places.
  • Report any signs of infection (fever, chills, sore throat) immediately.
  • Avoid activities that may cause cuts or bruising.
  • Use a soft toothbrush and gentle mouthwash to prevent mouth sores.
  • Stay well-hydrated.
  • Avoid sun exposure and use sunscreen/protective clothing, as this drug can cause photosensitivity.
  • Avoid alcohol and tobacco.
  • Discuss any over-the-counter medications, supplements, or herbal remedies with your doctor before taking them.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Highly variable based on indication, regimen (bolus vs. continuous infusion), and patient factors. Examples: Colorectal cancer (adjuvant): 400 mg/m² IV bolus on days 1-5, then 500 mg/m² IV bolus weekly for 4 weeks, repeated every 4-5 weeks. Or 400 mg/m² IV bolus followed by 2400-3000 mg/m² continuous IV infusion over 46 hours, every 2 weeks. Breast cancer: 500-600 mg/m² IV bolus on day 1, every 3-4 weeks, often in combination regimens.
Dose Range: 200 - 3000 mg

Condition-Specific Dosing:

Colorectal Cancer (adjuvant): 400 mg/m² IV bolus on days 1-5, then 500 mg/m² IV bolus weekly for 4 weeks, repeated every 4-5 weeks. Or 400 mg/m² IV bolus followed by 2400-3000 mg/m² continuous IV infusion over 46 hours, every 2 weeks.
Breast Cancer: 500-600 mg/m² IV bolus on day 1, every 3-4 weeks, often in combination regimens.
Gastric/Pancreatic Cancer: Often 500-600 mg/m² IV bolus weekly or 200-300 mg/m²/day continuous infusion, as part of combination regimens.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Dosing is highly individualized and based on specific protocols for pediatric cancers (e.g., medulloblastoma, osteosarcoma). Doses are typically calculated based on body surface area (BSA) and administered as part of multi-agent chemotherapy regimens. Consult specific pediatric oncology protocols.
Adolescent: Dosing is highly individualized and based on specific protocols for adolescent cancers. Doses are typically calculated based on body surface area (BSA) and administered as part of multi-agent chemotherapy regimens. Consult specific oncology protocols.
⚕️

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required, but use with caution and monitor for toxicity.
Moderate: No specific dose adjustment generally required, but use with caution and monitor for toxicity. Consider dose reduction if severe toxicity occurs.
Severe: No specific dose adjustment recommendations available; however, due to potential for increased toxicity, consider a 25-50% dose reduction and monitor closely. Use with extreme caution.
Dialysis: Fluorouracil is dialyzable. Administer after hemodialysis. Monitor for increased toxicity.

Hepatic Impairment:

Mild: No specific dose adjustment generally required, but use with caution and monitor for toxicity.
Moderate: No specific dose adjustment generally required, but use with caution and monitor for toxicity. Consider dose reduction if severe toxicity occurs.
Severe: No specific dose adjustment recommendations available; however, due to potential for increased toxicity, consider a 25-50% dose reduction and monitor closely. Use with extreme caution.

Pharmacology

🔬

Mechanism of Action

Fluorouracil (5-FU) is a pyrimidine analog antimetabolite. It acts by several mechanisms: 1. Inhibition of thymidylate synthase (TS): 5-FU is converted to 5-fluorodeoxyuridine monophosphate (FdUMP), which binds to and inhibits TS, an enzyme critical for DNA synthesis (specifically, the methylation of deoxyuridine monophosphate to deoxythymidine monophosphate). This leads to 'thymineless death' of rapidly dividing cells. 2. Incorporation into RNA: 5-FU is metabolized to 5-fluorouridine triphosphate (FUTP) and incorporated into RNA, interfering with RNA processing and protein synthesis. 3. Incorporation into DNA: 5-FU is metabolized to 5-fluorodeoxyuridine triphosphate (FdUTP) and can be incorporated into DNA, leading to DNA damage and fragmentation.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV administration)
Tmax: Not applicable (IV bolus) or continuous infusion steady state
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 0.12 L/kg (distributes widely into total body water, intestinal mucosa, bone marrow, liver, and malignant tumors)
ProteinBinding: <10%
CnssPenetration: Limited (crosses blood-brain barrier, but CSF concentrations are low and variable)

Elimination:

HalfLife: Biphasic: Initial phase ~10-20 minutes; Terminal phase ~6-20 hours (due to tissue binding and slower elimination of metabolites)
Clearance: Highly variable, influenced by DPD activity
ExcretionRoute: Renal (60-80% as inactive metabolites, 10-20% as unchanged drug)
Unchanged: 10-20%
⏱️

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of IV administration)
PeakEffect: Not directly applicable for cytotoxic effect; cellular effects are cumulative over time.
DurationOfAction: Cellular effects persist as long as active metabolites are present and incorporated, typically hours to days after administration.

Safety & Warnings

⚠️

BLACK BOX WARNING

WARNING: Fluorouracil should be used only by or under the supervision of a qualified physician experienced in cancer chemotherapy. Severe toxicities, some fatal, are associated with fluorouracil. These include myelosuppression, gastrointestinal toxicity (e.g., stomatitis, diarrhea, esophagopharyngitis), and neurotoxicity. The incidence and severity of toxicity are dose-related. Patients with dihydropyrimidine dehydrogenase (DPD) deficiency are at increased risk of severe, life-threatening, or fatal toxicity and should be identified prior to treatment if possible.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of nervous system problems, including:
+ Changes in mood or behavior
+ Confusion
+ Fever
+ Numbness or tingling in the hands or feet
+ Stiff neck
+ Sensitivity to bright lights
+ Severe muscle weakness
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Coffee ground-like vomit
+ Blood in the urine
+ Black, red, or tarry stools
+ Gum bleeding
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruising that worsens
+ Uncontrollable bleeding
Feeling extremely tired or weak
Chest pain or pressure
Shortness of breath, significant weight gain, or swelling in the arms or legs
Abnormal heartbeat
Dizziness or fainting
Changes in vision
Redness or irritation on the palms of the hands or soles of the feet
Balance problems
Excessive sleepiness
Uncontrolled eye movements
Headache

Administration Site Reactions

This medication may cause irritation at the injection site. If the medication leaks from the vein, it can also cause irritation around the affected area. Inform your nurse if you experience any redness, burning, pain, swelling, or fluid leakage at the injection site.

Other Possible Side Effects

Like all medications, this drug can cause side effects. However, many people may not experience any side effects or only minor ones. If you're concerned about any of the following side effects or if they persist, contact your doctor:

Diarrhea
Upset stomach or vomiting
Decreased appetite
Mouth irritation or mouth sores
Hair loss
Dry skin
Changes in nail condition

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever (100.4°F or higher) or chills
  • Severe diarrhea (more than 4-6 loose stools per day)
  • Severe mouth sores or pain in the mouth/throat
  • Unusual bleeding or bruising
  • Extreme fatigue or weakness
  • Chest pain or shortness of breath
  • Numbness, tingling, or weakness in hands or feet
  • Severe skin rash, redness, or blistering on palms or soles (hand-foot syndrome)
  • Signs of infection (e.g., redness, swelling, pain at injection site)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is crucial to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms.
Certain health conditions, such as:
+ Poor nutrition
+ Active infections
+ Bone marrow problems, including low white blood cell count, low platelet count, or low red blood cell count
+ Dihydropyrimidine dehydrogenase (DPD) deficiency
* If you are breast-feeding, as you should not breast-feed while taking this medication.

This list is not exhaustive, and it is essential to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests, as directed by your doctor, are crucial to monitor your condition.

This medication can cause low blood cell counts, which may lead to bleeding problems, infections, or anemia. In severe cases, these complications can be life-threatening. If you have any questions or concerns, discuss them with your doctor. You may be more susceptible to infections, so it is vital to practice good hygiene, such as washing your hands frequently, and avoid close contact with people who have infections, colds, or flu.

Bleeding can occur more easily while taking this medication, so it is crucial to be cautious and avoid injuries. To minimize the risk of bleeding, use a soft toothbrush and an electric razor. If you experience stomach upset, vomiting, diarrhea, or loss of appetite, consult your doctor, as they may be able to suggest ways to alleviate these side effects.

If you have diarrhea or vomiting, it is essential to discuss this with your doctor to prevent dehydration and electrolyte imbalances. Certain patients who lack the enzyme dihydropyrimidine dehydrogenase (DPD) are at a higher risk of developing severe and potentially life-threatening side effects, including mouth irritation or sores, diarrhea, low white blood cell counts, or nerve problems.

This medication may also increase the risk of heart problems, such as heart attack, heart failure, or abnormal heartbeat, particularly in individuals with a history of heart disease. Consult your doctor to discuss this risk. Before receiving any vaccinations, inform your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication.

You may be more prone to sunburn while taking this medication, so take necessary precautions when exposed to the sun. If you experience excessive sunburn, inform your doctor. This medication may also affect fertility, leading to difficulties in becoming pregnant or fathering a child. If you plan to conceive, discuss this with your doctor before starting treatment.

Additionally, this medication may harm the unborn baby if taken during pregnancy. If you or your partner may become pregnant, it is essential to use birth control while taking this medication and for a specified period after the last dose. Your doctor will advise you on the duration of birth control use. If you or your partner becomes pregnant, notify your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Severe myelosuppression (very low white blood cell count, platelet count)
  • Severe mucositis/stomatitis
  • Severe diarrhea
  • Gastrointestinal bleeding
  • Neurotoxicity (ataxia, confusion, seizures, coma)

What to Do:

There is no specific antidote for fluorouracil overdose. Management is supportive, including aggressive hydration, antiemetics, antidiarrheals, antibiotics for infection, and potentially uridine triacetate (Vistogard) if administered within 96 hours of overdose or early onset of severe toxicity. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.

Drug Interactions

🚫

Contraindicated Interactions

  • Brivudine (and other antiviral nucleoside analogues like sorivudine) - severe and potentially fatal toxicity due to inhibition of DPD, leading to increased 5-FU exposure.
🔴

Major Interactions

  • Leucovorin (folinic acid): Enhances the cytotoxic effect of fluorouracil by stabilizing the binding of FdUMP to thymidylate synthase, but also increases toxicity (e.g., myelosuppression, mucositis, diarrhea).
  • Capecitabine: Prodrug of fluorouracil; concurrent use leads to additive toxicity.
  • Live vaccines: Increased risk of infection due to immunosuppression.
  • Myelosuppressive agents (e.g., other chemotherapy, radiation therapy): Additive myelosuppression.
  • Cimetidine, Metronidazole: May increase 5-FU plasma concentrations and toxicity.
  • Warfarin: Increased anticoagulant effect (increased INR/bleeding risk).
🟡

Moderate Interactions

  • Phenytoin: May increase phenytoin levels and toxicity.
  • Allopurinol: May reduce the efficacy of fluorouracil by interfering with its activation (though some studies suggest it may reduce toxicity without compromising efficacy in certain settings).
  • Thiazide diuretics: May increase myelosuppression.
🟢

Minor Interactions

  • Not available

Monitoring

🔬

Baseline Monitoring

Complete Blood Count (CBC) with differential and platelets

Rationale: To establish baseline hematologic status and assess for pre-existing myelosuppression.

Timing: Prior to initiation of therapy

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, as 5-FU is primarily metabolized in the liver.

Timing: Prior to initiation of therapy

Renal Function Tests (Creatinine, BUN)

Rationale: To assess baseline renal function, as a portion of 5-FU and its metabolites are renally excreted.

Timing: Prior to initiation of therapy

DPD (Dihydropyrimidine Dehydrogenase) deficiency testing (optional but recommended by some guidelines)

Rationale: Patients with partial or complete DPD deficiency are at significantly increased risk of severe, life-threatening, or fatal toxicity from fluorouracil.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Complete Blood Count (CBC) with differential and platelets

Frequency: Prior to each dose/cycle, and as clinically indicated (e.g., twice weekly during continuous infusion)

Target: WBC >3,500/mm³, Neutrophils >1,500/mm³, Platelets >100,000/mm³ (may vary by protocol)

Action Threshold: Dose reduction or delay for significant myelosuppression (e.g., ANC <1,500/mm³, platelets <75,000/mm³)

Liver Function Tests (LFTs)

Frequency: Periodically, or as clinically indicated (e.g., every cycle)

Target: Within normal limits or stable baseline

Action Threshold: Significant elevation may warrant dose adjustment or discontinuation.

Renal Function Tests (Creatinine, BUN)

Frequency: Periodically, or as clinically indicated (e.g., every cycle)

Target: Within normal limits or stable baseline

Action Threshold: Significant elevation may warrant dose adjustment or discontinuation.

Electrolytes (especially potassium, magnesium, calcium)

Frequency: As clinically indicated, particularly with significant diarrhea or vomiting

Target: Within normal limits

Action Threshold: Correct imbalances promptly.

👁️

Symptom Monitoring

  • Signs of myelosuppression (fever, chills, sore throat, unusual bleeding/bruising, fatigue)
  • Gastrointestinal toxicity (severe diarrhea, mucositis/stomatitis, nausea, vomiting, abdominal pain)
  • Hand-foot syndrome (palmar-plantar erythrodysesthesia: redness, swelling, pain, blistering on palms/soles)
  • Neurological symptoms (ataxia, confusion, lethargy, headache, visual disturbances)
  • Cardiac symptoms (chest pain, shortness of breath, arrhythmias)
  • Skin reactions (rash, photosensitivity)
  • Hair loss (alopecia)

Special Patient Groups

🤰

Pregnancy

Fluorouracil is contraindicated in pregnancy (Pregnancy Category D). It can cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be advised to avoid becoming pregnant during therapy and to use effective contraception during treatment and for at least 6 months after the last dose.

Trimester-Specific Risks:

First Trimester: Highest risk of major congenital malformations and fetal death.
Second Trimester: Risk of fetal growth restriction, organ toxicity, and fetal death.
Third Trimester: Risk of fetal growth restriction, myelosuppression, and other toxicities.
🤱

Lactation

Fluorouracil is contraindicated during breastfeeding (Lactation Risk L5). It is unknown if fluorouracil is excreted in human milk, but due to the potential for serious adverse reactions in the breastfed infant, breastfeeding should be discontinued during therapy and for at least 1 month after the last dose.

Infant Risk: High risk of serious adverse effects, including myelosuppression, gastrointestinal toxicity, and growth inhibition.
👶

Pediatric Use

Fluorouracil is used in pediatric oncology for specific indications, but dosing is highly individualized based on body surface area and specific treatment protocols. Pediatric patients may be more susceptible to certain toxicities. Close monitoring is essential.

👴

Geriatric Use

Elderly patients (≥65 years) may be at increased risk of severe toxicity (e.g., myelosuppression, gastrointestinal toxicity, neurotoxicity) due to decreased organ function, comorbidities, and polypharmacy. Careful monitoring, dose adjustments, and supportive care are crucial. Consider starting with a lower dose and titrating based on tolerance.

Clinical Information

💎

Clinical Pearls

  • DPD deficiency is a critical risk factor for severe, potentially fatal toxicity. Consider DPD testing, especially in patients with early or unusually severe toxicity.
  • Leucovorin is often co-administered with fluorouracil to enhance its cytotoxic effect, but this also increases toxicity. The dose and schedule of leucovorin are crucial.
  • Hand-foot syndrome (palmar-plantar erythrodysesthesia) is a common and often dose-limiting toxicity. Patient education on prevention (e.g., avoiding friction/heat, moisturizing) and early recognition is important.
  • Severe diarrhea and mucositis are common and can be life-threatening. Aggressive supportive care, including antidiarrheals and pain management, is essential.
  • Cardiac toxicity (e.g., angina, MI, arrhythmias) is rare but can occur, especially in patients with pre-existing cardiac disease. Monitor for cardiac symptoms.
  • Neurotoxicity, though less common, can range from mild (e.g., lethargy, confusion) to severe (e.g., ataxia, seizures).
  • Fluorouracil is a vesicant/irritant; ensure proper IV access and monitor for extravasation.
🔄

Alternative Therapies

  • Capecitabine (oral prodrug of 5-FU)
  • Other antimetabolites (e.g., Gemcitabine, Pemetrexed, Cytarabine)
  • Other classes of chemotherapy agents (e.g., platinum agents, taxanes, topoisomerase inhibitors)
  • Targeted therapies (e.g., EGFR inhibitors, VEGF inhibitors)
  • Immunotherapy (e.g., PD-1/PD-L1 inhibitors)
💰

Cost & Coverage

Average Cost: Varies widely, typically $50 - $200 per 50ml vial (2.5gm)
Generic Available: Yes
Insurance Coverage: Tier 4 (Specialty/Non-Preferred Brand) or Tier 2/3 (Generic) for injectable, depending on plan formulary. Often covered under medical benefit for oncology.
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance.

To ensure safe use, do not share your medication with others, and never take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion.

Proper disposal of unused or expired medications is crucial. Do not flush medications down the toilet or pour them down the drain unless specifically instructed to do so by your pharmacist or healthcare provider. If you are unsure about the best method for disposing of medications, consult with your pharmacist, who can provide guidance on safe disposal practices. Additionally, you may want to inquire about potential drug take-back programs in your area.

Some medications may come with an additional patient information leaflet. If you have any questions or concerns about your medication, it is recommended that you consult with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide detailed information about the overdose, including the type and amount of medication taken, as well as the time it occurred, to ensure prompt and effective treatment.